5 insider filings
Daljit Singh Aurora, insider filing for NMRA
Show all 5
- 4Insider filing for NMRA
- 4Insider filing for NMRA
- 4Insider filing for NMRA
- 4Insider filing for NMRA
- 4Insider filing for NMRA
Daljit Singh Aurora, reporting
NMRA
Neumora Therapeutics, Inc. SEC filings
Every EDGAR filing for Neumora Therapeutics, Inc. (NMRA), newest first, with AI summaries and stories.
- Ticker
- NMRA
- CIK
- 1885522
- Latest filing
- Aug 21
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4Neumora Therapeutics, Inc.NMRALIVE ROUTINE144Neumora Therapeutics, Inc.NMRALIVE Daljit Singh Aurora, planned sale of NMRA shares
Daljit Singh Aurora, reporting
ROUTINE144Neumora Therapeutics, Inc.NMRALIVE Daljit Singh Aurora, planned sale of NMRA shares
Daljit Singh Aurora, reporting
ROUTINE4Neumora Therapeutics, Inc.NMRALIVE Daljit Singh Aurora, insider filing for NMRA
Daljit Singh Aurora, reporting
ROUTINE144Neumora Therapeutics, Inc.NMRALIVE Daljit Singh Aurora, planned sale of NMRA shares
Daljit Singh Aurora, reporting
ROUTINE144Neumora Therapeutics, Inc.NMRALIVE Daljit Singh Aurora, planned sale of NMRA shares
Daljit Singh Aurora, reporting
ROUTINE144Neumora Therapeutics, Inc.NMRALIVE Daljit Singh Aurora, planned sale of NMRA shares
Daljit Singh Aurora, reporting
NOTABLE10-QNeumora Therapeutics, Inc.NMRALIVE ROUTINE8-KNeumora Therapeutics, Inc.NMRALIVE ROUTINE8-KNeumora Therapeutics, Inc.NMRALIVE ROUTINE8-KNeumora Therapeutics, Inc.NMRALIVE ROUTINE4Neumora Therapeutics, Inc.NMRALIVE 5 insider filings
Kristina Burow, insider filing for NMRA
Show all 5
- 4Insider filing for NMRA
- 4Insider filing for NMRA
- 4Insider filing for NMRA
- 4Insider filing for NMRA
- 4Insider filing for NMRA
Kristina Burow, reporting
ROUTINE8-KNeumora Therapeutics, Inc.NMRALIVE ROUTINESCHEDULE 13G/ANeumora Therapeutics, Inc.NMRALIVE Ownership stake disclosure by K2 HealthVentures Equity Trust LLC (amended)
K2 HealthVentures Equity Trust LLC, filed by
NOTABLE10-QNeumora Therapeutics, Inc.NMRALIVE ROUTINE8-KNeumora Therapeutics, Inc.NMRALIVE ROUTINESCHEDULE 13G/ANeumora Therapeutics, Inc.NMRALIVE Ownership stake disclosure by Invus Global Management, LLC (amended)
Invus Global Management, LLC, filed by
ROUTINEDEFA14ANeumora Therapeutics, Inc.NMRALIVE ROUTINEDEF 14ANeumora Therapeutics, Inc.NMRALIVE NOTABLESCHEDULE 13D/ANeumora Therapeutics, Inc.NMRALIVE Ownership stake disclosure by ARCH Venture Fund XII, L.P. (amended)
ARCH Venture Fund XII, L.P., filed by
ROUTINES-8Neumora Therapeutics, Inc.NMRALIVE NOTABLE10-KNeumora Therapeutics, Inc.NMRALIVE ROUTINE8-KNeumora Therapeutics, Inc.NMRALIVE ROUTINE4Neumora Therapeutics, Inc.NMRALIVE 4 insider filings
Daljit Singh Aurora, insider filing for NMRA
Show all 4
- 4Insider filing for NMRA
- 4Insider filing for NMRA
- 4Insider filing for NMRA
- 4Insider filing for NMRA
Daljit Singh Aurora, reporting
ROUTINESCHEDULE 13GNeumora Therapeutics, Inc.NMRALIVE Ownership stake disclosure by Invus Global Management, LLC
Invus Global Management, LLC, filed by
ROUTINESCHEDULE 13G/ANeumora Therapeutics, Inc.NMRALIVE Ownership stake disclosure by K2 HealthVentures Equity Trust LLC (amended)
K2 HealthVentures Equity Trust LLC, filed by
ROUTINE144Neumora Therapeutics, Inc.NMRALIVE 4 Form 144 notices
Joshua Pinto, planned sale of NMRA shares
Show all 4
- 144Planned insider sale of NMRA shares
- 144Planned insider sale of NMRA shares
- 144Planned insider sale of NMRA shares
- 144Planned insider sale of NMRA shares
Joshua Pinto, reporting
ROUTINE8-KNeumora Therapeutics, Inc.NMRALIVE ROUTINE8-KNeumora Therapeutics, Inc.NMRALIVE ROUTINE4Neumora Therapeutics, Inc.NMRALIVE 5 insider filings
Michael Lee Milligan, insider filing for NMRA
Show all 5
- 4Insider filing for NMRA
- 4Insider filing for NMRA
- 4Insider filing for NMRA
- 4Insider filing for NMRA
- 4Insider filing for NMRA
Michael Lee Milligan, reporting
ROUTINE8-KNeumora Therapeutics, Inc.NMRALIVE NOTABLE8-KNeumora Therapeutics, Inc.NMRALIVE Neumora Therapeutics, Inc. filed 8-K current report
- Item 3.02
- Item 9.01